Cargando…

The protective role of EP300 in monocrotaline-induced pulmonary hypertension

BACKGROUND: Pulmonary hypertension (PH) is a lethal disease characterized by pulmonary vascular remodeling, which is mediated by the abnormal proliferation/migration of pulmonary arterial smooth muscle cells (PASMCs). Recent reports suggest the involvement of histone acetylation in PAH development a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Lei, Tian, Jinglin, Wang, Jun, Zeng, Jie, Wang, Ting, Lin, Boya, Linneman, John, Li, Li, Niu, Yanqin, Gou, Deming, Zhang, Yunhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992637/ https://www.ncbi.nlm.nih.gov/pubmed/36910531 http://dx.doi.org/10.3389/fcvm.2023.1037217

Ejemplares similares

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022)

Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCγ1 axis
por: Xu, Junhua, et al.
Publicado: (2022)

Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model
por: Wang, Yun, et al.
Publicado: (2011)

Protective Effects of 18β-Glycyrrhetinic Acid on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Zhang, Min, et al.
Publicado: (2019)

MicroRNAs in Pulmonary Hypertension, from Pathogenesis to Diagnosis and Treatment
por: Xu, Junhua, et al.
Publicado: (2022)

Role of miR‐21‐5p/FilGAP axis in estradiol alleviating the progression of monocrotaline‐induced pulmonary hypertension
por: Hu, Xiaoyi, et al.
Publicado: (2022)

Quercetin attenuates the progression of monocrotaline-induced pulmonary hypertension in rats
por: Gao, Hanhua, et al.
Publicado: (2012)

Shikonin improves pulmonary vascular remodeling in monocrotaline‑induced pulmonary arterial hypertension via regulation of PKM2
por: Li, Wenfeng, et al.
Publicado: (2023)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018)

Lodenafil treatment in the monocrotaline model of pulmonary hypertension in rats
por: Polonio, Igor Bastos, et al.
Publicado: (2014)

Arginase Inhibition Reverses Monocrotaline-Induced Pulmonary Hypertension
por: Jung, Christian, et al.
Publicado: (2017)

Cannabidiol Ameliorates Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Sadowska, Olga, et al.
Publicado: (2020)

Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats
por: Jiang, Wei-Long, et al.
Publicado: (2019)

Inhibitory effects of formononetin on the monocrotaline-induced pulmonary arterial hypertension in rats
por: Wu, Yonghui, et al.
Publicado: (2020)

Protective Effects of Methylsulfonylmethane on Hemodynamics and Oxidative Stress in Monocrotaline-Induced Pulmonary Hypertensive Rats
por: Mohammadi, Sadollah, et al.
Publicado: (2012)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
por: Tang, Yi, et al.
Publicado: (2022)

Decoding ceRNA regulatory network in the pulmonary artery of hypoxia-induced pulmonary hypertension (HPH) rat model
por: Wang, Jun, et al.
Publicado: (2022)

Postpartum pulmonary circulation in pregnant rats with monocrotaline-induced pulmonary arterial hypertension
por: Jing, He, et al.
Publicado: (2020)

Thymosin Beta 4 Protects Mice from Monocrotaline-Induced Pulmonary Hypertension and Right Ventricular Hypertrophy
por: Wei, Chuanyu, et al.
Publicado: (2014)

Pulmonary vessel casting in a rat model of monocrotaline-mediated pulmonary hypertension
por: Zhu, Zhongkai, et al.
Publicado: (2020)

Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
por: Dahal, Bhola K, et al.
Publicado: (2011)

Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010)

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension
por: Kosanovic, Djuro, et al.
Publicado: (2011)

The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Izikki, Mohamed, et al.
Publicado: (2013)

Magnesium Sulfate Mitigates the Progression of Monocrotaline Pulmonary Hypertension in Rats
por: Chang, Chao-Yuan, et al.
Publicado: (2019)

Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats
por: Ding, Mingge, et al.
Publicado: (2015)

Protective Effect of Right Ventricular Mitochondrial Damage by Cyclosporine A in Monocrotaline-induced Pulmonary Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2018)

Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline
por: Qin, Tianyou, et al.
Publicado: (2022)

Protective effect of hydrogen sulfide on monocrotaline-induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition
por: Zhang, Hui, et al.
Publicado: (2019)

Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats
por: Cheng, Yusheng, et al.
Publicado: (2018)

Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension
por: Zhang, Wei-hua, et al.
Publicado: (2014)

Integrated analysis of m(6)A mRNA methylation in rats with monocrotaline-induced pulmonary arterial hypertension
por: Zeng, Yunhong, et al.
Publicado: (2021)

Protective effect of nicotinamide and l-arginine against monocrotaline-induced pulmonary hypertension in rats: gender dependence
por: Sztormowska-Achranowicz, Katarzyna, et al.
Publicado: (2020)

Protective Effect of Triclosan in Monocrotaline-Induced Pulmonary Arterial Hypertension: FASN Inhibition a Novel Approach
por: Alsabeelah, Nimer, et al.
Publicado: (2022)

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats
por: Chaumais, Marie-Camille, et al.
Publicado: (2014)

Monocrotaline Induces Endothelial Injury and Pulmonary Hypertension by Targeting the Extracellular Calcium–Sensing Receptor
por: Xiao, Rui, et al.
Publicado: (2017)

MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways
por: Cai, Zongye, et al.
Publicado: (2018)

Formononetin attenuates monocrotaline-induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats
por: Cai, Changhong, et al.
Publicado: (2019)

The protective effects of PCPA against monocrotaline-induced pulmonary arterial hypertension are mediated through the downregulation of NFAT-1 and NF-κB
por: Bai, Yang, et al.
Publicado: (2017)

Hypoxic pulmonary vasoconstriction and vascular contractility in monocrotaline-induced pulmonary arterial hypertensive rats
por: Kim, Hae Jin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p6hnvm5bfsprrmojr0q6vfnn1q